Clinical trials
Recruiting Psychotic Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Douglas Mental Health University Institute | 5 |
| Nova Scotia Health Authority | 4 |
| Centre for Addiction and Mental Health | 3 |
| The Royal Ottawa Mental Health Centre | 3 |
| University of Toronto | 2 |
| BC Mental Health and Addictions Research Institute | 1 |
| Bristol-Myers Squibb | 1 |
| Ciusss de L'Est de l'Île de Montréal | 1 |
| Fraser Health | 1 |
| MapLight Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psychotic Disorders | 25 |
| Schizophrenia | 13 |
| Marijuana Abuse | 4 |
| Mental Disorders | 4 |
| Substance-Related Disorders | 4 |
| Alcoholism | 3 |
| Anxiety Disorders | 3 |
| Bipolar Disorder | 3 |
| Alzheimer Disease | 2 |
| Attention Deficit Disorder with Hyperactivity | 2 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.